Alan Seth Krasner, Chief Medical Officer at Crinetics Pharmaceuticals, Inc. (CRNX), sold 6,700 shares at $21.21 ($142K) on 2022-01-19, disclosed to the SEC on 2022-01-21.
Open-market sale of $142k CRNX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BIOD | SELL | 2012-11-05 | $10K | — | Filing → |
| BIOD | SELL | 2011-09-22 | $5K | — | Filing → |